Bruker Corporation

NasdaqGS:BRKR 株式レポート

時価総額：US$8.1b

Bruker マネジメント

マネジメント 基準チェック /44

Brukerの CEO はFrank Laukienで、 Feb1991年に任命され、 の在任期間は 33.75年です。 の年間総報酬は$ 5.86Mで、 15.8%給与と84.2%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の26.55%を直接所有しており、その価値は$ 2.15B 。経営陣と取締役会の平均在任期間はそれぞれ10.6年と9.3年です。

主要情報

Frank Laukien

最高経営責任者

US$5.9m

報酬総額

CEO給与比率15.8%
CEO在任期間33.8yrs
CEOの所有権26.5%
経営陣の平均在職期間10.6yrs
取締役会の平均在任期間9.3yrs

経営陣の近況

Recent updates

Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Nov 14
Bruker's (NASDAQ:BRKR) Anemic Earnings Might Be Worse Than You Think

Bruker: Still Challenged, Certainly Margins

Nov 02

Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

Oct 25
Earnings Tell The Story For Bruker Corporation (NASDAQ:BRKR)

We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Sep 10
We Think Bruker (NASDAQ:BRKR) Is Taking Some Risk With Its Debt

Bruker: Multiple Risks And Declining Returns On Capital Aren't Priced In

Aug 22

Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 22
Is It Too Late To Consider Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Jun 09
Bruker Corporation's (NASDAQ:BRKR) Business Is Yet to Catch Up With Its Share Price

Bruker: A Confusing Acquisition Spree

May 31

Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

May 09
Bruker's (NASDAQ:BRKR) Promising Earnings May Rest On Soft Foundations

Bruker Corporation: An Aggressive Acquisition Strategy

Apr 24

Bruker Offers Upside With Key Enabling Technologies For Future Bio-Pharma Research

Apr 11

Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

Jan 22
Calculating The Fair Value Of Bruker Corporation (NASDAQ:BRKR)

There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Jan 08
There's Reason For Concern Over Bruker Corporation's (NASDAQ:BRKR) Price

Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Dec 26
Should You Be Adding Bruker (NASDAQ:BRKR) To Your Watchlist Today?

Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Nov 06
Is Bruker Corporation (NASDAQ:BRKR) Potentially Undervalued?

Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Oct 23
Is Bruker (NASDAQ:BRKR) Using Too Much Debt?

Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Sep 25
Here's Why Bruker (NASDAQ:BRKR) Has Caught The Eye Of Investors

Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Aug 09
Does This Valuation Of Bruker Corporation (NASDAQ:BRKR) Imply Investors Are Overpaying?

Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Jul 27
Is Now The Time To Look At Buying Bruker Corporation (NASDAQ:BRKR)?

Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

Jul 11
Bruker (NASDAQ:BRKR) Has A Pretty Healthy Balance Sheet

CEO報酬分析

Bruker の収益と比較して、Frank Laukien の報酬はどのように変化したか？
日付総報酬給与会社業績
Sep 30 2024n/an/a

US$305m

Jun 30 2024n/an/a

US$352m

Mar 31 2024n/an/a

US$402m

Dec 31 2023US$6mUS$926k

US$427m

Sep 30 2023n/an/a

US$319m

Jun 30 2023n/an/a

US$319m

Mar 31 2023n/an/a

US$312m

Dec 31 2022US$5mUS$873k

US$297m

Sep 30 2022n/an/a

US$275m

Jun 30 2022n/an/a

US$274m

Mar 31 2022n/an/a

US$282m

Dec 31 2021US$6mUS$812k

US$277m

Sep 30 2021n/an/a

US$270m

Jun 30 2021n/an/a

US$238m

Mar 31 2021n/an/a

US$204m

Dec 31 2020US$4mUS$689k

US$158m

Sep 30 2020n/an/a

US$158m

Jun 30 2020n/an/a

US$165m

Mar 31 2020n/an/a

US$177m

Dec 31 2019US$5mUS$753k

US$197m

Sep 30 2019n/an/a

US$207m

Jun 30 2019n/an/a

US$189m

Mar 31 2019n/an/a

US$184m

Dec 31 2018US$4mUS$731k

US$180m

Sep 30 2018n/an/a

US$98m

Jun 30 2018n/an/a

US$92m

Mar 31 2018n/an/a

US$84m

Dec 31 2017US$5mUS$704k

US$79m

報酬と市場: Frankの 総報酬 ($USD 5.86M ) は、 US市場 ($USD 7.94M ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Frankの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Frank Laukien (64 yo)

33.8yrs

在職期間

US$5,858,761

報酬

Dr. Frank H. Laukien, Ph D., serves as the Chairman, Chief Executive Officer and President of Bruker Corporation at Bruker BioSpin GmbH since February 1991. Dr. Laukien serves as the Chairman, Chief Execut...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Frank Laukien
Chairman33.8yrsUS$5.86m26.55%
$ 2.1b
Gerald Herman
Executive VP & CFO6.7yrsUS$2.20m0.033%
$ 2.6m
Mark Munch
Corporate Executive VP and President of Bruker Nano Group & Corporate9.3yrsUS$2.73m0.050%
$ 4.1m
Juergen Srega
President of Bruker CALID Group & Bruker Daltonics Division11.8yrsUS$1.47m0.081%
$ 6.6m
Falko Busse
President of Bruker BioSpin Group6.5yrsUS$1.35m0.016%
$ 1.3m
Justin Ward
Senior Director of Investor Relations & Corporate Developmentno dataデータなしデータなし
J. Alldredge
General Counsel & Secretaryno dataデータなしデータなし
Burkhard Prause
President and CEO of Bruker Energy & Supercon Technologies16.6yrsUS$967.91k0.0090%
$ 726.6k

10.6yrs

平均在職期間

62yo

平均年齢

経験豊富な経営陣: BRKRの経営陣は経験豊富で経験豊富です（平均在職期間は10.6年）。

取締役

名称ポジション在職期間報酬所有権
Frank Laukien
Chairman33.8yrsUS$5.86m26.55%
$ 2.1b
John Ornell
Independent Director9.3yrsUS$241.01k0.014%
$ 1.1m
Robert Rosenthal
Independent Director9yrsUS$224.01k0.019%
$ 1.5m
Richard Packer
Independent Director17.5yrsUS$227.32k0.047%
$ 3.8m
William Linton
Independent Lead Director24.8yrsUS$231.01k0.022%
$ 1.8m
Adelene Perkins
Independent Director7.5yrsUS$224.01k0.013%
$ 1.0m
Hermann Requardt
Independent Director9.3yrsUS$219.01k0.014%
$ 1.1m
Bonnie Anderson
Independent Director4.2yrsUS$219.65k0.0050%
$ 408.6k
Cynthia Friend
Independent Director8.5yrsUS$216.83k0.0076%
$ 618.1k

9.3yrs

平均在職期間

66yo

平均年齢

経験豊富なボード: BRKRの 取締役会 は 経験豊富 であると考えられます ( 9.3年の平均在任期間)。